The newsletter today is just this quick hello and the brief missive below. We’ll be off tomorrow.
***
It’s not that there’s nothing out there.
There is a ton to process. I’d recommend taking a spin through the collection of links that is KFF’s always-useful Morning Briefing if you’re really looking for something to read.
But, reality check: no one knows anything for sure.
To wit: STAT’s look at what biotech and pharma executives expect out of Trump 2.0 uses the word “could” ten times, including the headline. The word also appears in the headline of STAT’s RFK Jr. piece and its Medicaid article. It uses “might” in the headline of its FDA piece.
I’m not picking on STAT here. Pretty much all of the coverage is similarly caveated. That doesn’t mean it’s not helpful: journalists are beginning to define the range of possibilities for health regulation over the next four years.
But it’s probably not worth a lot of in-depth analysis here. The reality will become clear soon enough, and there will be plenty to talk about when that happens.
